Investor Overview

Corporate Profile

Accuray develops, manufactures and sells radiation oncology systems that make cancer treatments shorter, safer, smarter and more effective. Accuray provides treatment delivery technologies that set the industry standard for precision and cover the full range of radiation therapy and radiosurgery treatments, as well as fully integrated software solutions that drive faster, smarter treatment planning.

Press Releases

August 16, 2018 at 4:05 PM EDT

Summary Toggle Accuray Reports Fourth Quarter and Fiscal 2018 Financial Results

SUNNYVALE, Calif. , Aug. 16, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2018 . Q4 Fiscal 2018 and Recent Operating Highlights Gross orders increased 12 percent to $96.4 million Revenue increased to
July 25, 2018 at 7:30 AM EDT

Summary Toggle Addenbrooke's Hospital is First in the UK to Treat Cancer Patients with Accuray Radixact® System

Internationally Renowned Centre in Cambridge, England is First NHS Hospital to Install the Innovative Radiation Therapy System SUNNYVALE, Calif. , July 25, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Addenbrooke's Hospital clinical team has treated the first

View All

Events

View All

Annual Reports

Filing date	Form
Aug 24, 2018	10-K
Aug 25, 2017	10-K

View All

Investor Relations

Innovating patient-first cancer treatments.

Investor Overview

Corporate Profile

Investor Relations

Innovating patient-first cancer treatments.

Investor Overview

Corporate Profile

Connect with us on social media.